Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, Pardal F, Suriano G, Machado JC, Lopes JM, Reis RM. Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res. 2007 May 1;13(9):2621-6. doi: 10.1158/1078-0432.CCR-06-2606. PubMed PMID: 17473192.
Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, Reis RM, Costello JF. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res. 2010 Jan 15;70(2):453-62. doi: 10.1158/0008-5472.CAN-09-2189. Epub 2010 Jan 12. PubMed PMID: 20068170; PubMed Central PMCID: PMC2849935.
Costa BM, Caeiro C, Guimarães I, Martinho O, Jaraquemada T, Augusto I, Castro L, Osório L, Linhares P, Honavar M, Resende M, Braga F, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires M, Pinheiro C, Carvalho E, Lopes JM, Costa P, Damasceno M, Reis RM. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study. Oncol Rep. 2010 Jun;23(6):1655-62. doi: 10.3892/or_00000808. PubMed PMID: 20428822.
Araújo AP, Costa BM, Pinto-Correia AL, Fragoso M, Ferreira P, Dinis-Ribeiro M, Costa S, Reis RM, Medeiros R. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians. World J Gastroenterol. 2011 Jan 28;17(4):488-92. doi: 10.3748/wjg.v17.i4.488. PubMed PMID: 21274378; PubMed Central PMCID: PMC3027015.
Costa BM, Viana-Pereira M, Fernandes R, Costa S, Linhares P, Vaz R, Pinheiro C, Lima J, Soares P, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires MM, Pinheiro C, Carvalho E, Oliveira P, Lopes JM, Reis RM. Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2610-7. doi: 10.1158/1055-9965.EPI-11-0340. Epub 2011 Sep 29. PubMed PMID: 21960689.
Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec;13(12):1331-8. doi: 10.1093/neuonc/nor130. Epub 2011 Sep 6. PubMed PMID: 21896554; PubMed Central PMCID: PMC3223090.
de Mello RA, Costa BM, Reis RM, Hespanhol V. Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies. Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):118-31. doi: 10.2174/157489212798357994. Review. PubMed PMID: 21854359.
de Mello RA, Ferreira M, Costa S, Costa BM, Pires FS, Neves I, Almeida MI, Cunha J, Oliveira P, Hespanhol V, Reis RM. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study. Tumour Biol. 2012 Oct;33(5):1341-8. doi: 10.1007/s13277-012-0382-7. Epub 2012 Mar 29. PubMed PMID: 22457050.
Rodrigues AJ, Leão P, Pêgo JM, Cardona D, Carvalho MM, Oliveira M, Costa BM, Carvalho AF, Morgado P, Araújo D, Palha JA, Almeida OF, Sousa N. Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids. Mol Psychiatry. 2012 Dec;17(12):1295-305. doi: 10.1038/mp.2011.126. Epub 2011 Oct 4. PubMed PMID: 21968930.
Pojo M, Cerqueira SR, Mota T, Xavier-Magalhães A, Ribeiro-Samy S, Mano JF, Oliveira J, Reis RL, Sousa N, Costa BM, Salgado AJ. In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models. Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology. 2013 May; (15):1621. doi: 10.1007/s11051-013-1621-6.
Xavier-Magalhães A, Nandhabalan M, Jones C, Costa BM. Molecular prognostic factors in glioblastoma: state of the art and future challenges. CNS Oncol. 2013 Nov;2(6):495-510. doi: 10.2217/cns.13.48. Review. PubMed PMID: 25054820; PubMed Central PMCID: PMC6136097.
Pires-Luís AS, Vieira-Coimbra M, Vieira FQ, Costa-Pinheiro P, Silva-Santos R, Dias PC, Antunes L, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication. Epigenetics. 2015;10(11):1033-43. doi: 10.1080/15592294.2015.1103578. PubMed PMID: 26488939; PubMed Central PMCID: PMC4844211.
Pojo M, Gonçalves CS, Xavier-Magalhães A, Oliveira AI, Gonçalves T, Correia S, Rodrigues AJ, Costa S, Pinto L, Pinto AA, Lopes JM, Reis RM, Rocha M, Sousa N, Costa BM. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget. 2015 Apr 10;6(10):7657-74. doi: 10.18632/oncotarget.3150. PubMed PMID: 25762636; PubMed Central PMCID: PMC4480707.
Costa-Pinheiro P, Ramalho-Carvalho J, Vieira FQ, Torres-Ferreira J, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. MicroRNA-375 plays a dual role in prostate carcinogenesis. Clin Epigenetics. 2015;7:42. doi: 10.1186/s13148-015-0076-2. eCollection 2015. PubMed PMID: 25977730; PubMed Central PMCID: PMC4431534.
Salgado AJ, Sousa JC, Costa BM, Pires AO, Mateus-Pinheiro A, Teixeira FG, Pinto L, Sousa N. Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities. Front Cell Neurosci. 2015;9:249. doi: 10.3389/fncel.2015.00249. eCollection 2015. Review. PubMed PMID: 26217178; PubMed Central PMCID: PMC4499760.
Vieira de Castro J, Gonçalves CS, Costa S, Linhares P, Vaz R, Nabiço R, Amorim J, Viana-Pereira M, Reis RM, Costa BM. Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumour Biol. 2015 Aug;36(8):6525-32. doi: 10.1007/s13277-015-3343-0. Epub 2015 Mar 27. PubMed PMID: 25813152.
Gonçalves CS, Xavier-Magalhães A, Pojo M, Oliveira AI, Correia S, Reis RM, Sousa N, Rocha M, Costa BM. Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models. Genom Data. 2015 Sep;5:54-8. doi: 10.1016/j.gdata.2015.05.010. eCollection 2015 Sep. PubMed PMID: 26484224; PubMed Central PMCID: PMC4583997.
Vieira JP, Lopes F, Silva-Fernandes A, Sousa MV, Moura S, Sousa S, Costa BM, Barbosa M, Ylstra B, Temudo T, Lourenço T, Maciel P. Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene. Int J Dev Neurosci. 2015 Nov;46:82-7. doi: 10.1016/j.ijdevneu.2015.07.010. Epub 2015 Aug 10. PubMed PMID: 26287660.
Fogli A, Chautard E, Vaurs-Barrière C, Pereira B, Müller-Barthélémy M, Court F, Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival. Carcinogenesis. 2016 Feb;37(2):169-176. doi: 10.1093/carcin/bgv251. Epub 2015 Dec 30. PubMed PMID: 26717998.
Bell RJ, Rube HT, Xavier-Magalhães A, Costa BM, Mancini A, Song JS, Costello JF. Understanding TERT Promoter Mutations: A Common Path to Immortality. Mol Cancer Res. 2016 Apr;14(4):315-23. doi: 10.1158/1541-7786.MCR-16-0003. Epub 2016 Mar 3. Review. PubMed PMID: 26941407; PubMed Central PMCID: PMC4852159.
Miranda-Gonçalves V, Granja S, Martinho O, Honavar M, Pojo M, Costa BM, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Reis RM, Baltazar F. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 2016 Jul 19;7(29):46335-46353. doi: 10.18632/oncotarget.10114. PubMed PMID: 27331625; PubMed Central PMCID: PMC5216802.
Almeida-Rios D, Graça I, Vieira FQ, Ramalho-Carvalho J, Pereira-Silva E, Martins AT, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer. Oncotarget. 2016 Aug 16;7(33):53018-53028. doi: 10.18632/oncotarget.10061. PubMed PMID: 27323813; PubMed Central PMCID: PMC5288165.
Xavier-Magalhães A, Oliveira AI, de Castro JV, Pojo M, Gonçalves CS, Lourenço T, Viana-Pereira M, Costa S, Linhares P, Vaz R, Nabiço R, Amorim J, Pinto AA, Reis RM, Costa BM. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. J Neurooncol. 2017 Mar;132(1):27-34. doi: 10.1007/s11060-016-2345-0. Epub 2017 Jan 12. PubMed PMID: 28083786.
Carvalho MR, Maia FR, Silva-Correia J, Costa BM, Reis RL, Oliveira JM. A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking. Nanomedicine (Lond). 2017 Mar;12(6):581-596. doi: 10.2217/nnm-2016-0344. Epub 2017 Feb 10. PubMed PMID: 28186438.
Oliveira AI, Anjo SI, Vieira de Castro J, Serra SC, Salgado AJ, Manadas B, Costa BM. Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells. Cell Commun Signal. 2017 Oct 2;15(1):37. doi: 10.1186/s12964-017-0194-x. PubMed PMID: 28969644; PubMed Central PMCID: PMC5625790.
Vieira de Castro J, Gomes ED, Granja S, Anjo SI, Baltazar F, Manadas B, Salgado AJ, Costa BM. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology. J Transl Med. 2017 Oct 2;15(1):200. doi: 10.1186/s12967-017-1303-8. PubMed PMID: 28969635; PubMed Central PMCID: PMC5625623.
Celus W, Di Conza G, Oliveira AI, Ehling M, Costa BM, Wenes M, Mazzone M. Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis. Cell Rep. 2017 Dec 5;21(10):2842-2854. doi: 10.1016/j.celrep.2017.11.034. PubMed PMID: 29212030; PubMed Central PMCID: PMC5732321.
Ferreira MJ, Pires-Luís AS, Vieira-Coimbra M, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. Epigenetics. 2017;12(12):1057-1064. doi: 10.1080/15592294.2017.1385685. Epub 2018 Jan 22. PubMed PMID: 29099276; PubMed Central PMCID: PMC5810786.
Oliveira AI, Xavier-Magalhães A, Moreira-Barbosa C, Magalhães H, Henrique R, Jerónimo C, Costa BM. Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival. Biomark Med. 2018 Mar;12(3):257-264. doi: 10.2217/bmm-2017-0258. Epub 2018 Feb 13. PubMed PMID: 29436234.
Xavier-Magalhães A, Gonçalves CS, Fogli A, Lourenço T, Pojo M, Pereira B, Rocha M, Lopes MC, Crespo I, Rebelo O, Tão H, Lima J, Moreira R, Pinto AA, Jones C, Reis RM, Costello JF, Arnaud P, Sousa N, Costa BM. The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget. 2018 Mar 20;9(21):15740-15756. doi: 10.18632/oncotarget.24597. eCollection 2018 Mar 20. PubMed PMID: 29644006; PubMed Central PMCID: PMC5884661.
Ramalho-Carvalho J, Gonçalves CS, Graça I, Bidarra D, Pereira-Silva E, Salta S, Godinho MI, Gomez A, Esteller M, Costa BM, Henrique R, Jerónimo C. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97. Clin Epigenetics. 2018;10:40. doi: 10.1186/s13148-018-0475-2. eCollection 2018. PubMed PMID: 29599847; PubMed Central PMCID: PMC5870254.
Gonçalves CS, Vieira de Castro J, Pojo M, Martins EP, Queirós S, Chautard E, Taipa R, Pires MM, Pinto AA, Pardal F, Custódia C, Faria CC, Clara C, Reis RM, Sousa N, Costa BM. WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018;8(17):4805-4823. doi: 10.7150/thno.25025. eCollection 2018. PubMed PMID: 30279739; PubMed Central PMCID: PMC6160775.
Mancini A, Xavier-Magalhães A, Woods WS, Nguyen KT, Amen AM, Hayes JL, Fellmann C, Gapinske M, McKinney AM, Hong C, Jones LE, Walsh KM, Bell RJA, Doudna JA, Costa BM, Song JS, Perez-Pinera P, Costello JF. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. Cancer Cell. 2018 Sep 10;34(3):513-528.e8. doi: 10.1016/j.ccell.2018.08.003. PubMed PMID: 30205050; PubMed Central PMCID: PMC6135086.
Gomes ED, Vieira de Castro J, Costa BM, Salgado AJ. The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas. Biochimie. 2018 Dec;155:59-66. doi: 10.1016/j.biochi.2018.07.008. Epub 2018 Jul 19. Review. PubMed PMID: 30031037.
Salgado AJ, Gimble JM, Costa BM. The cell secretome in personalized and regenerative medicine. Biochimie. 2018 Dec;155:1. doi: 10.1016/j.biochi.2018.11.004. Epub 2018 Nov 9. PubMed PMID: 30419261.
Brown P, Zhou Y. Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database. 2019 October; 2019. doi: https://doi.org/10.1093/database/baz085.
Branco M, Linhares P, Carvalho B, Santos P, Costa BM, Vaz R. Serum lactate levels are associated with glioma malignancy grade. Clin Neurol Neurosurg. 2019 Nov;186:105546. doi: 10.1016/j.clineuro.2019.105546. Epub 2019 Oct 1. PubMed PMID: 31605893.
Estevão-Pereira H, Lobo J, Salta S, Amorim M, Lopes P, Cantante M, Reis B, Antunes L, Castro F, Palma de Sousa S, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer. J Transl Med. 2019 Dec 30;17(1):435. doi: 10.1186/s12967-019-02193-y. PubMed PMID: 31888645; PubMed Central PMCID: PMC6936051.
Gonçalves CS, Le Boiteux E, Arnaud P, Costa BM. HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours. Cell Mol Life Sci. 2020 Apr 1;. doi: 10.1007/s00018-020-03508-9. [Epub ahead of print] Review. PubMed PMID: 32239260.
Monteiro-Reis S, Lameirinhas A, Miranda-Gonçalves V, Felizardo D, Dias PC, Oliveira J, Graça I, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion. Cancers (Basel). 2020 Apr 25;12(5). doi: 10.3390/cancers12051066. PubMed PMID: 32344886; PubMed Central PMCID: PMC7281198.
Gonçalves CS, Xavier-Magalhães A, Martins EP, Pinto AA, Pires MM, Pinheiro C, Reis RM, Sousa N, Costa BM. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Mol Oncol. 2020 Jun;14(6):1224-1241. doi: 10.1002/1878-0261.12633. Epub 2020 May 6. PubMed PMID: 31923345; PubMed Central PMCID: PMC7266278.
Outeiro-Pinho G, Barros-Silva D, Aznar E, Sousa AI, Vieira-Coimbra M, Oliveira J, Gonçalves CS, Costa BM, Junker K, Henrique R, Jerónimo C. MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples. J Exp Clin Cancer Res. 2020 Jun 1;39(1):98. doi: 10.1186/s13046-020-01600-3. PubMed PMID: 32487203; PubMed Central PMCID: PMC7323611.
Oliveira-Pinto S, Pontes O, Lopes D, Sampaio-Marques B, Costa MD, Carvalho L, Gonçalves CS, Costa BM, Maciel P, Ludovico P, Baltazar F, Proença F, Costa M. Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment. Bioorg Chem. 2020 Jul;100:103942. doi: 10.1016/j.bioorg.2020.103942. Epub 2020 May 17. PubMed PMID: 32450388.
Vieira de Castro J, Gonçalves CS, Hormigo A, Costa BM. Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. Int J Mol Sci. 2020 Jul 25;21(15). doi: 10.3390/ijms21155278. Review. PubMed PMID: 32722427; PubMed Central PMCID: PMC7432229.
What would you like to do?
  • Page of 1